The Dutch lithography giant is navigating a treacherous stretch. Just days ago, shares touched an all-time high of €1,748, but the euphoria has faded as a fresh wave of geopolitical and commercial headwinds tests investor confidence. At around €1,608 on Thursday, the stock has slipped roughly 8% from that peak, even as it remains up nearly 63% since the start of the year.
The immediate threat comes from Washington. US lawmakers introduced the MATCH Act in April, a bill that would impose a blanket export ban on deep ultraviolet (DUV) lithography systems to China, and even prohibit servicing of existing machines already on the mainland. The Hague has formally joined the US-led “Pax-Silica Alliance”, signalling far tighter controls on older DUV tools. China has historically been a crucial engine for ASML, representing roughly 20% of planned system sales for 2026. Losing that demand would carve a deep hole in the order book.
US Commerce Secretary Howard Lutnick has further escalated tensions, accusing ASML in recent discussions of having delivered a cutting-edge EUV machine to China — a direct violation of US sanctions. The company flatly denies the claim, insisting it has never sold such equipment or components to Beijing. But with legislation advancing, the risk of a complete shutdown of China-related revenue is no longer theoretical.
On the commercial side, the largest customers are tapping the brakes. TSMC and other chipmakers are delaying the rollout of the new High-NA EUV platforms, which cost as much as €400 million per machine. Instead, they are pivoting toward cheaper advanced packaging alternatives. This means ASML’s hefty order backlog is converting into revenue more slowly than anticipated. The delay comes at a critical moment: successfully scaling High-NA from 2026 onward was supposed to compensate for any sales lost to export restrictions.
Should investors sell immediately? Or is it worth buying Asml?
Yet the longer-term growth story is far from broken. Industry body SEMI forecasts that global spending on advanced fab equipment will soon smash through the $52 billion mark — a record. ASML’s management is counting on this investment wave and has guided for up to €40 billion in revenue by 2026. UBS analysts see enough momentum to lift their price target to €2,100, citing rising earnings expectations, a monopoly position in advanced lithography and sustained high demand for high-performance memory and logic chips.
But caution flags are waving elsewhere. Bank of America recently warned that its proprietary risk indicator for the tech sector is flashing red, pointing to overheated valuations. Adding to the unease, OpenAI researchers have reportedly found code optimisations that could significantly reduce hardware requirements for AI workloads — a potential efficiency shock that could curb demand for ASML’s most advanced machines.
The next crucial catalyst arrives on July 15, when ASML reports its second-quarter results. If management reaffirms the €40 billion 2026 revenue target and provides a stable outlook on High-NA adoption, the stock’s underlying narrative remains intact. A cautious update on China, or any signal that TSMC is permanently stepping back from next-generation tools, could send shares sliding toward the 100-day moving average near €1,313.89. For now, the market is watching Washington and Taipei as closely as Eindhoven.
Ad
Asml Stock: Buy or Sell?! New Asml Analysis from October 2 delivers the answer:
The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 2.
Asml: Buy or sell? Read more here...
